Education
About Us
Working with TipRanks
Follow Us
Gemina Laboratories Ltd. (TSE:GLAB)
:GLAB
Total Valuation
Gemina Laboratories Ltd. has a market cap or net worth of C$6.13M. The enterprise value is C$57.67M.
Market CapC$6.13M
Enterprise ValueC$57.67M
Share Statistics
Gemina Laboratories Ltd. has 76,570,910 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding76,570,910
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Gemina Laboratories Ltd.’s return on equity (ROE) is 0.92 and return on invested capital (ROIC) is 123.74%.
Return on Equity (ROE)0.92
Return on Assets (ROA)-2.83
Return on Invested Capital (ROIC)123.74%
Return on Capital Employed (ROCE)0.92
Revenue Per Employee0.00
Profits Per Employee-678.94K
Employee Count6
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Gemina Laboratories Ltd. is ―. Gemina Laboratories Ltd.’s PEG ratio is 0.42.
PE Ratio―
PS Ratio0.00
PB Ratio-9.02
Price to Fair Value-9.02
Price to FCF-30.74
Price to Operating Cash Flow-65.68
PEG Ratio0.42
Income Statement
In the last 12 months, Gemina Laboratories Ltd. had revenue of 0.00 and earned -4.07M in profits. Earnings per share was -0.06.
Revenue0.00
Gross Profit-113.24K
Operating Income-3.91M
Pretax Income-4.07M
Net Income-4.07M
EBITDA-3.80M
Earnings Per Share (EPS)-0.06
Cash Flow
In the last 12 months, operating cash flow was -465.26K and capital expenditures 0.00, giving a free cash flow of -465.26K billion.
Operating Cash Flow-465.26K
Free Cash Flow-465.26K
Free Cash Flow per Share>-0.01
Dividends & Yields
Gemina Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.86
52-Week Price Change-89.87%
50-Day Moving Average0.33
200-Day Moving Average0.71
Relative Strength Index (RSI)18.67
Average Volume (3m)13.56K
Important Dates
Gemina Laboratories Ltd. upcoming earnings date is Dec 18, 2025, After Close (Confirmed).
Last Earnings DateSep 26, 2025
Next Earnings DateDec 18, 2025
Ex-Dividend Date―
Financial Position
Gemina Laboratories Ltd. as a current ratio of 0.02, with Debt / Equity ratio of -5.54%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.02
Net Debt to EBITDA-0.34
Interest Coverage Ratio-23.84
Taxes
In the past 12 months, Gemina Laboratories Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Gemina Laboratories Ltd. EV to EBITDA ratio is -10.87, with an EV/FCF ratio of -31.72.
EV to Sales0.00
EV to EBITDA-10.87
EV to Free Cash Flow-31.72
EV to Operating Cash Flow-31.72
Balance Sheet
Gemina Laboratories Ltd. has C$14.97K in cash and marketable securities with C$243.65K in debt, giving a net cash position of -C$228.68K billion.
Cash & Marketable SecuritiesC$14.97K
Total DebtC$243.65K
Net Cash-C$228.68K
Net Cash Per Share>-C$0.01
Tangible Book Value Per Share-C$0.06
Margins
Gross margin is -416.73%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-416.73%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Gemina Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast9.06%